Colony Group’s iShares Biotechnology ETF IBB Stock Holding History

Colony Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$435K	Buy	3,561 +103	+3%	+$13.1K	0.01%	578
2023 Q2	$439K	Hold	3,458	–	–	0.01%	589
2023 Q1	$447K	Sell	3,458 -50	-1%	-$6.54K	0.01%	580
2022 Q4	$461K	Hold	3,508	–	–	0.01%	639
2022 Q3	$410K	Buy	+3,508	New	+$436K	0.01%	608
2022 Q2	–	Sell	-1,665	Closed	-$217K	–	835
2022 Q1	$217K	Sell	1,665 -69,721	-98%	-$9.08M	﹤0.01%	793
2021 Q4	$10.9M	Buy	71,386 +69,008	+2,902%	+$10.7M	0.19%	101
2021 Q3	$384K	Sell	2,378 -150	-6%	-$25.2K	0.01%	626
2021 Q2	$414K	Buy	2,528 +75	+3%	+$11.6K	0.01%	572
2021 Q1	$369K	Sell	2,453 -1,312	-35%	-$208K	0.01%	601
2020 Q4	$570K	Buy	3,765 +1,312	+53%	+$188K	0.01%	475
2020 Q3	$332K	Hold	2,453	–	–	0.01%	559
2020 Q2	$335K	Buy	+2,453	New	+$313K	0.01%	530
2018 Q2	–	Sell	-2,045	Closed	-$218K	–	513
2018 Q1	$218K	Buy	+2,045	New	+$227K	0.01%	459
2016 Q1	–	Sell	-201	Closed	-$23K	–	419
2015 Q4	$23K	Buy	+201	New	+$21.8K	﹤0.01%	547

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Colony Group's IBB Position: Q3 2023 in Review

Colony Group increased its iShares Biotechnology ETF (IBB) stake by 3% in Q3 2023, buying an estimated $13.1K and bringing the position to 3,561 shares worth $435K. The position accounts for 0.01% of the portfolio, ranked #578.

Colony Group first reported a position in IBB in Q4 2015 and has held it in 15 quarters since. The position peaked at $10.9M in Q4 2021. 833 funds tracked by Wall St. Rank hold IBB as of Q3 2023.

Colony Group held 3,561 shares of iShares Biotechnology ETF worth $435K as of Q3 2023.
Colony Group bought 103 iShares Biotechnology ETF shares in Q3 2023, an estimated $13.1K.
iShares Biotechnology ETF made up 0.01% of Colony Group's portfolio in Q3 2023, its #578 holding.
Colony Group first reported a position in iShares Biotechnology ETF in Q4 2015 and has held it in 15 quarters since.
Colony Group's iShares Biotechnology ETF position peaked at $10.9M in Q4 2021.
833 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2023.

Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.